140 related articles for article (PubMed ID: 3711361)
1. A survey of drug and therapeutics committees operating in Ireland.
Ferrando MC; Henman MC
J Clin Hosp Pharm; 1986 Apr; 11(2):131-40. PubMed ID: 3711361
[TBL] [Abstract][Full Text] [Related]
2. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.
Fadare JO; Ogunleye O; Obiako R; Orubu S; Enwere O; Ajemigbitse AA; Meyer JC; Enato E; Massele A; Godman B; Gustafsson LL
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1255-1262. PubMed ID: 30451035
[No Abstract] [Full Text] [Related]
3. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
[TBL] [Abstract][Full Text] [Related]
4. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
[TBL] [Abstract][Full Text] [Related]
5. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
Plumridge RJ; Stoelwinder JU; Rucker TD
Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
[TBL] [Abstract][Full Text] [Related]
6. Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.
Shankar PR; Humagain B; Piryani RM; Jha N; Osti B
Pharm World Sci; 2009 Apr; 31(2):241-5. PubMed ID: 19058026
[TBL] [Abstract][Full Text] [Related]
7. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
Sterné SC; Uchida KM; Iteen SA
Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
[No Abstract] [Full Text] [Related]
8. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
Friesen P; Caplan AL; Miller JE
J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
[TBL] [Abstract][Full Text] [Related]
9. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
Pedersen CA; Schneider PJ; Scheckelhoff DJ
Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
[TBL] [Abstract][Full Text] [Related]
10. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.
Fijn R; Brouwers JR; Knaap RJ; De Jong-Van Den Berg LT
Br J Clin Pharmacol; 1999 Aug; 48(2):239-46. PubMed ID: 10417503
[TBL] [Abstract][Full Text] [Related]
11. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.
Plet HT; Hallas J; Nielsen GS; Kjeldsen LJ
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):264-9. PubMed ID: 23107106
[TBL] [Abstract][Full Text] [Related]
12. Drug and Therapeutics Committees in Australia: expected and actual performance.
Weekes LM; Brooks C
Br J Clin Pharmacol; 1996 Nov; 42(5):551-7. PubMed ID: 8951185
[TBL] [Abstract][Full Text] [Related]
13. Prioritising drug and therapeutics committee (DTC) decisions: a national survey.
Tan EL; Day RO; Brien JA
Pharm World Sci; 2007 Apr; 29(2):90-6. PubMed ID: 17187221
[TBL] [Abstract][Full Text] [Related]
14. Improving the performance of Drug and Therapeutics Committees in hospitals--a quasi-experimental study in Laos.
Vang C; Tomson G; Kounnavong S; Southammavong T; Phanyanouvong A; Johansson R; Eriksson B; Wahlstrom R
Eur J Clin Pharmacol; 2006 Jan; 62(1):57-63. PubMed ID: 16372173
[TBL] [Abstract][Full Text] [Related]
15. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
Matlala M; Gous AG; Godman B; Meyer JC
Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
[TBL] [Abstract][Full Text] [Related]
16. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
Penm J; Chaar B; Dechun J; Moles R
Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
[TBL] [Abstract][Full Text] [Related]
17. The management of a hospital formulary.
Sutters CA
J Clin Pharm Ther; 1990 Feb; 15(1):59-76. PubMed ID: 2318917
[TBL] [Abstract][Full Text] [Related]
18. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
Pedersen CA; Schneider PJ; Santell JP
Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on Drug and Therapeutics Committee policy implementation.
Tan EL; Day RO; Brien JA
Res Social Adm Pharm; 2005 Dec; 1(4):526-45. PubMed ID: 17138494
[TBL] [Abstract][Full Text] [Related]
20. Pilot drug and therapeutic committee programme in Sierra Leone: A descriptive mixed method study.
Kabba JA; Koroma MM; James PB; Kitchen C; Xu S; Chang J; Saeed A; Malik UR; Jiang M; Fang Y
Br J Clin Pharmacol; 2023 Jan; 89(1):20-33. PubMed ID: 33398910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
